Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$970,072
+$363,095 QoQ
Shares Held
3,855
+17.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,571
of 4,153 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2023CallValue
$122,658,755
CallShares
791,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,328,883,667 across 8 Drug Manufacturers - General names. ABBV ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,429,349 | $460,653,157 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,216,892 | $406,422,135 | |
| 3 | LLY |
ELI LILLY & Co
|
176,517 | $211,719,802 | |
| 4 | NVS |
Novartis AG
|
1,037,332 | $162,570,671 | |
| 5 | MRK |
Merck & Co., Inc.
|
628,000 | $80,698,000 | |
| 6 | JNJ |
Johnson & Johnson
|
18,956 | $4,814,255 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $1,035,575 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
3,855 | $970,072 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $970,072 | 3,855 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $606,977 | 3,270 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,639,752 | 65,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $196,739,133 | 1,107,142 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $204,973,603 | 1,195,042 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $226,351,938 | 1,243,009 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $257,326,600 | 1,660,493 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $122,658,755 | 791,500 | Call | Sole | 2024-02-14 | |
| 2021-12-31 | $300,073,480 | 2,216,200 | Call | Sole | 2022-02-14 | |
| 2021-12-31 | $164,755,532 | 1,216,806 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $195,552,453 | 1,812,853 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $210,670,110 | 1,953,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $122,008,381 | 1,083,171 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $103,482,368 | 918,700 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $97,398,000 | 900,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $96,092,866 | 887,940 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $133,128,946 | 1,242,454 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $94,932,319 | 1,083,826 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $60,623,302 | 617,471 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||